Skip to Content Skip to Footer

This Week@WesternU, July 2-6, 2018

by Rodney Tanaka

July 2, 2018

Read 3 mins

From the College of Health Sciences:

College of Allied Health Professions changes name
The College of Allied Health Professions at Western University of Health Sciences is changing its name to the College of Health Sciences (CHS), effective July 1, 2018.

CHS has expanded its mission and vision beyond the allied health professions to a broader scope of health sciences. The name change reflects the comprehensive mission of WesternU.

“Expanding scope, potential, and service provision by becoming the College of Health Sciences provides a pathway to develop future-oriented programs to serve the health care needs of the region beyond the allied health professions,” said College of Health Sciences Dean Stephanie Bowlin, EdD, PA. “Health care needs in the 21st century present exciting opportunities for the College of Health Sciences to develop innovative solutions.”

Click here to read the full story and to watch videos promoting the name change.

 

 

From the College of Veterinary Medicine:

WesternU College of Veterinary Medicine Professor’s TEDxUCLA talk available online
Western University of Health Sciences College of Veterinary Medicine Professor Tracey McNamara, DVM, Diplomate ACVP, was a featured speaker at the TEDxUCLA conference “Waves” in April 2018. Her full presentation, “Canaries in the coal mine,” is now available online: https://www.youtube.com/watch?v=qm8NnL582uc. Please watch the video, “like” it and share it with others.

Click here to read the full story.

 

 

From the College of Podiatric Medicine:

Kudos on accomplishments
College of Podiatric Medicine Professor and WesternU Foot and Ankle Center Medical Director Jonathan Labovitz, DPM, FACFAS, CHCQM, served as chair of the California Podiatric Medical Association’s Western Foot and Ankle Conference, which was held at the Disneyland Hotel and Convention Center June 21-24. There were more than 1,100 attendees and lectures were given by CPM faculty Drs. Rebecca Moellmer, Jarrod Shapiro and Jacqueline Truong, COMP faculty Dr. Marcel Fraix, and COP faculty Drs. Huan Mark Nguyen and Doreen Pon.

 

 

From the College of Pharmacy:

WesternU researchers receive NIH funding to study skin cancer prevention
Western University of Health Sciences researchers received National Institutes of Health funding to potentially repurpose a drug commonly used to treat high blood pressure to protect against the sun-induced cell damage that leads to skin cancer. 

College of Pharmacy (COP) Associate Professor Ying Huang, MD, PhD, was awarded $409,223 in NIH funding through an R15 grant titled “Topical Delivery of Non-β-blocking R-carvedilol for Prevention of UV-induced Skin Cancer.” 

This three-year project addresses the unmet need of skin cancer, the most common type of cancer worldwide. The proposed studies aim to repurpose R-carvedilol, an enantiomer in the racemic β-blocker carvedilol, an FDA-approved cardiovascular drug, for skin cancer prevention. COP Associate Professor Bradley Andresen, PhD, FAHA, COP Professor Jeffrey Wang, PhD, and College of Osteopathic Medicine of the Pacific Professor Cyrus Parsa, DO, serve as co-investigators. 

Click here to read the full story.

 

Kudos on accomplishments
Kugler AJ, Thiman ML. Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data. Diabetes Metab Syndr Obes. 2018 May 9;11:187-197. doi: 10.2147/DMSO.S134960. eCollection 2018.

https://www.dovepress.com/efficacy-and-safety-profile-of-once-weekly-dulaglutide-in-type-2-diabe-peer-reviewed-article-DMSO

Chow SL, Page RL, Depre C. Role of ivabradine and heart rate lowering in chronic heart failure: guideline update.  Expert Rev Cardiovasc Ther. 2018 Jun 14. doi: 10.1080/14779072.2018.1489235. [Epub ahead of print] https://www.tandfonline.com/doi/abs/10.1080/14779072.2018.1489235

Xiao Chen,Xiang Gao,Jie Chen, Chow SL, Chow MSS. New direction for clinical pharmacy in China: adopting a “form follows function” approach to improve future healthcare outcomes. Journal of Chinese Pharmaceutical Sciences, 2018, 27(5): 352-360. http://www.jcps.ac.cn/EN/Y2018/V27/I5/352

Dr. Benjamin Malcolm received his certification in psychiatric pharmacy, BCPP (Board Certified Psychiatric Pharmacist).

Dr. James Scott is certified as an Advanced Practice Pharmacist (APh). Dr Scott is the fourth PPAD faculty so far to receive this certification.

PPAD faculty and post-docs are well represented in the current issue of Journal of Contemporary Pharmacy Practice, Vol. 65 (2). Dr. Sun Lee was a fellow of Dr. Anandi Law, and had just completed her training. 

Jackevicius C. Critical Appraisal of Non-Inferiority Randomized Controlled Trials. J Contemp Pharm Pract 2018; 65(2):26.

Lee S, An J. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis (PRECISION). J Contemp Pharm Pract 2018; 65(2):27-33.

Lee S, Hata M, Law AV. Medication Disposal: The Final Step in Medication Safety. J Contemp Pharm Pract 2018; 65(2):34-40.

Recommended Stories